Abstract
No public abstract is available from the verified source records.
Martin Ganter, Müller Kerstin, J. Böttcher, K. Donat, M. Eschbaumer, J. Gethmann, M. Holsteg, J. Hilke, L. Kreienbrock, M. Bastian, U. Truyen, C.G. Baums, S. Rautenschlein
Abstract
Authors
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Bundesamt für Lebensmittelsicherheit und Veterinärwesen
2025
Bundesamt für Lebensmittelsicherheit und Veterinärwesen
2025
Foot-and-mouth disease confirmed in Hungary
10.1002/vetr.5335 · 2025
Unresolved referenced work
Kept as external metadata until matched
Unresolved referenced work
Kept as external metadata until matched
Emergence of foot-and-mouth disease virus SAT 1 topotype III in Iran: molecular and phylogenetic analysis
10.1007/s11262-026-02230-1 · 2026
Unresolved referenced work
2026
Unresolved referenced work
2026
Unresolved referenced work
Kept as external metadata until matched
Unresolved referenced work
Kept as external metadata until matched
The foot-and-mouth disease epidemic of 2001 in the UK: implications for the USA and the war on terror
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
unpaywall
Confidence 95%
datacite
Confidence 0%
10.3138/jvme.30.2.121 · 2003
2023/361 of 28 November 2022 supplementing regulation (EU) 2016/429 of the European parliament and the council as regards rules for the use of certain veterinary medicinal products for the purpose of prevention and control of certain listed diseases
2023
Kapitel XVI - Bekämpfung
1980
Review of the status of foot and mouth disease and approach to control/eradication in Europe and Central Asia
10.20506/rst.21.3.1345 · 2002
Conclusions from the outbreak of foot-and-mouth disease in the government district of Hannover in 1987/1988
1990
Unresolved referenced work
1990
Unresolved referenced work
2001
The foot and mouth disease (FMD) epidemic in the United Kingdom 2001
10.1016/s0147-9571(02)00030-9 · 2002
Some costs of animal disease outbreaks cannot be counted
2002
The 2001 foot and mouth disease epidemic in the United Kingdom: animal welfare perspectives
10.20506/rst.21.3.1380 · 2002
The foot-and-mouth disease epidemic in the Netherlands in 2001
10.1016/s0167-5877(02)00217-9 · 2003
Unresolved referenced work
Kept as external metadata until matched
Foot-and-mouth disease control using vaccination: the Dutch experience in 2001
2004
Unresolved referenced work
2025
Unresolved referenced work
2002
Chapter 8.8 - infection with foot and mouth disease virus
2024
Unresolved referenced work
Kept as external metadata until matched
2016/429 of the European parliament and of the council of 9 March 2016 on transmissible animal diseases and amending and repealing certain acts in the area of animal health (‘animal health law’)
2016
Vaccines and foot-and-mouth disease eradication in South America
2003
Review of the status of foot and mouth disease in countries of South America and approaches to control and eradication
10.20506/rst.21.3.1350 · 2002
Control of a foot-and-mouth disease epidemic in Argentina
10.1016/j.prevetmed.2004.08.002 · 2004
Factors associated with within-herd transmission of serotype a foot-and-mouth disease virus in cattle, during the 2001 outbreak in Argentina: a protective effect of vaccination
10.1111/j.1865-1682.2011.01217.x · 2011
Strategy for the control of foot-and-mouth disease in Uruguay
2004
Main factors associated with foot-and-mouth disease virus infection during the 2001 FMD epidemic in Uruguay
10.3389/fvets.2023.1070188 · 2023
The use of vaccines in South American foot-and-mouth disease eradication programmes
2004
Current status and future prospects to achieve Foot-and-mouth disease eradication in South America
10.1111/tbed.12345 · 2017
Advances in the eradication of foot-and-mouth disease in South America: 2011-2020
2022
Reemergence of foot-and-mouth disease, South Korea, 2000-2011
10.3201/eid2012.130518 · 2014
Epidemiological characteristics of foot-and-mouth disease in the Republic of Korea, 2014-2019
10.1016/j.prevetmed.2021.105284 · 2021
Post-vaccination monitoring to assess Foot-and-mouth disease immunity at population level in Korea
10.3389/fvets.2021.673820 · 2021
Evaluating vaccination strategies to control foot-and-mouth disease: a country comparison study
10.1017/s0950268818001243 · doi-reference
Economics of eradicating foot-and-mouth disease epidemics with alternative control strategies
10.4067/s0301-732x2014000300006 · doi-reference
Evaluation of the benefit of emergency vaccination in a foot-and-mouth disease free country with low livestock density
10.1016/j.prevetmed.2013.10.015 · doi-reference
A simulation study of the use of vaccination to control foot-and-mouth disease outbreaks across Australia
10.3389/fvets.2021.648003 · doi-reference
Comparing control strategies against foot-and-mouth disease: will vaccination be cost-effective in Denmark?
10.1016/j.prevetmed.2013.05.008 · doi-reference
Vaccination against foot-and-mouth disease I: epidemiological consequences
10.1016/j.prevetmed.2012.05.012 · doi-reference
Epidemiology and economics of foot-and-mouth disease: current understanding and knowledge gaps
10.1186/s13567-025-01561-5 · doi-reference
Economic costs of the foot and mouth disease outbreak in the United Kingdom in 2001
10.20506/rst.21.3.1353 · doi-reference
The economic impacts of foot and mouth disease - what are they, how big are they and where do they occur?
10.1016/j.prevetmed.2013.07.013 · doi-reference
Application of non-structural protein antibody tests in substantiating freedom from foot-and-mouth disease virus infection after emergency vaccination of cattle
10.1016/j.vaccine.2006.06.032 · doi-reference
Comparative evaluation of six ELISAs for the detection of antibodies to the non-structural proteins of foot-and-mouth disease virus
10.1016/j.vaccine.2006.04.050 · doi-reference
Antibodies to foot-and-mouth disease virus infection associated (VIA) antigen: use of a bioengineered VIA protein as antigen in an ELISA
10.1016/0378-1135(89)90047-3 · doi-reference
Differentiating infection from vaccination in foot-and-mouth-disease: evaluation of an ELISA based on recombinant 3ABC
10.1016/j.vetmic.2004.01.021 · doi-reference
Development of novel strategies to control foot-and-mouth disease: marker vaccines and antivirals
10.1016/j.biologicals.2005.08.009 · doi-reference
Differentiation of foot-and-mouth disease virus infected animals from vaccinated animals using a blocking ELISA based on baculovirus expressed FMDV 3ABC antigen and a 3ABC monoclonal antibody
10.1007/s00705-004-0455-z · doi-reference
Foot-and-mouth disease: the agar gel diffusion precipitin test for antibody to virus-infection-associated (VIA) antigen as a tool for epizootiologic surveys
10.1093/oxfordjournals.aje.a121207 · doi-reference
Rate of foot-and-mouth disease virus transmission by carriers quantified from experimental data
10.1111/j.1539-6924.2008.01020.x · doi-reference
Vaccination against foot-and-mouth disease virus confers complete clinical protection in 7 days and partial protection in 4 days: use in emergency outbreak response
10.1016/j.vaccine.2005.07.043 · doi-reference
Further evaluation of higher potency vaccines for early protection of cattle against FMDV direct contact challenge
10.1016/j.vaccine.2007.07.067 · doi-reference
Protection against direct-contact challenge following emergency FMD vaccination of cattle and the effect on virus excretion from the oropharynx
10.1016/j.vaccine.2004.08.034 · doi-reference
Effect of emergency FMD vaccine antigen payload on protection, sub-clinical infection and persistence following direct contact challenge of cattle
10.1016/j.vaccine.2006.01.037 · doi-reference
PRAGMATIST: a tool to prioritize foot-and-mouth disease virus antigens held in vaccine banks
10.3389/fvets.2022.1029075 · doi-reference
International bank for foot-and-mouth disease vaccine: stability studies with virus concentrates and vaccines prepared from them
10.1016/0264-410x(90)90249-l · doi-reference
Selection of foot and mouth disease vaccine strains--a review
10.20506/rst.24.3.1632 · doi-reference
FMD vaccine matching: inter laboratory study for improved understanding of r(1) values
10.1016/j.jviromet.2019.113786 · doi-reference
Predicting cross-protection against foot-and-mouth disease virus strains by serology after vaccination
10.3389/fvets.2022.1027006 · doi-reference
High potency vaccines induce protection against heterologous challenge with foot-and-mouth disease virus
10.1016/j.vaccine.2008.01.038 · doi-reference
FMD vaccines
10.1016/s0168-1702(02)00261-7 · doi-reference
Emergency vaccination against foot-and-mouth disease: rate of development of immunity and its implications for the carrier state
10.1016/0264-410x(94)90262-3 · doi-reference
Emergency vaccination of pigs against foot-and-mouth disease: protection against disease and reduction in contact transmission
10.1016/s0264-410x(97)86180-4 · doi-reference
Evidence that high potency foot-and-mouth disease vaccine inhibits local virus replication and prevents the “carrier” state in sheep
10.1016/j.vaccine.2003.09.024 · doi-reference
FMD vaccines: reflections on quality aspects for applicability in European disease control policy
10.1111/j.1865-1682.2007.01012.x · doi-reference
Hypersensitivity in cattle after foot-and-mouth disease vaccination: response to hydroxpropylmethylcellulose
10.1017/s0022172400047082 · doi-reference
Analysis of factors associated with hesitation to restart farming after depopulation of animals due to 2010 foot-and-mouth disease epidemic in Japan
10.1292/jvms.15-0559 · doi-reference